发明申请
US20120190853A1 BENZOIMIDAZOLYL-PYRAZINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
失效
用于炎症和免疫相关用途的苯并咪唑氨基吡嗪化合物
- 专利标题： BENZOIMIDAZOLYL-PYRAZINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
- 专利标题（中）： 用于炎症和免疫相关用途的苯并咪唑氨基吡嗪化合物
-
申请号： US13353713申请日： 2012-01-19
-
公开(公告)号： US20120190853A1公开(公告)日： 2012-07-26
- 发明人: Shoujun Chen , Jun Jiang , Junyi Zhang , Yu Xie
- 申请人： Shoujun Chen , Jun Jiang , Junyi Zhang , Yu Xie
- 申请人地址： US MA Lexington
- 专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人地址： US MA Lexington
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; C07D471/04 ; C07D413/14 ; C07D401/14 ; C07D417/14
摘要：
The invention relates to compounds of structural formula (I) or (III): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein ring A, X1, X2, X3, X5, R1, R4, Y, Z, L, m and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
公开/授权文献
信息查询
